Controlling Microenvironments with Organs-on-Chips for Osteoarthritis Modelling

Cells. 2023 Feb 10;12(4):579. doi: 10.3390/cells12040579.

Abstract

Osteoarthritis (OA) remains a prevalent disease affecting more than 20% of the global population, resulting in morbidity and lower quality of life for patients. The study of OA pathophysiology remains predominantly in animal models due to the complexities of mimicking the physiological environment surrounding the joint tissue. Recent development in microfluidic organ-on-chip (OoC) systems have demonstrated various techniques to mimic and modulate tissue physiological environments. Adaptations of these techniques have demonstrated success in capturing a joint tissue's tissue physiology for studying the mechanism of OA. Adapting these techniques and strategies can help create human-specific in vitro models that recapitulate the cellular processes involved in OA. This review aims to comprehensively summarise various demonstrations of microfluidic platforms in mimicking joint microenvironments for future platform design iterations.

Keywords: cell microenvironment; disease models; organ-on-chip; osteoarthritis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Microfluidics / methods
  • Models, Animal
  • Osteoarthritis*
  • Quality of Life*

Grants and funding

This work is supported Australian Research Council (FT180100157 and DP200101658) awarded to YCT, QUT DVC ECR grant (323100-0235) awarded to LJYO. ARS is funded by the QUT ECR Scheme (323100-0415), Roland Bishop Award (323100-0412), Center for Biomedical Technologies (CBT) E/MCR Scheme 2022–2023 (324910-0009). IP is funded by CBT IE scheme 2022–2023 (324910-0004). LM is funded by the China Scholarship Council (CSC) Grant #202206370184 from the Ministry of Education of P.R. China. X.F. acknowledges QUT Postgraduate Research Award (QUTPRA) and QUT HDR Tuition Fee Sponsorship.